Application Nr Approved Date Route Status External Links
NDA205382 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Incruse Ellipta Is Indicated For The Maintenance Treatment Of Patients With Chronic Obstructive Pulmonary Disease (Copd). Incruse Ellipta Is An Anticholinergic Indicated For The Maintenance Treatment Of Patients With Chronic Obstructive Pulmonary Disease (Copd). ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Umeclidinium Bromide UMECLIDINIUM BROMIDE ZINC34608502

Comments